GenAge entry for SIRT1 (Homo sapiens)

Entry selected based on evidence directly linking the gene product to ageing in a mammalian model organism

Gene name (HAGRID: 150)

HGNC symbol
SIRT1 
Aliases
SIR2L1 
Common name
sirtuin 1 

Potential relevance to the human ageing process

Main reason for selection
Entry selected based on evidence directly linking the gene product to ageing in a mammalian model organism
Description

SIRT1 is a NAD-dependent deacetylase, which can regulate a number of processes by deacetylating key proteins, such as TP53 [734]. In yeast, the SIRT1 homologue sir2 has been linked to cellular senescence [200]. Increasing the levels of SIRT1 homologues in fruit flies [1284] and roundworms [199] extends lifespan, although these findings have been questioned by other studies [3321].

SIRT1-null mice are born smaller than controls with evidence of developmental retardation. Depending on their genetic background, SIRT1-null mice either die shortly after birth or reach adulthood, the latter being smaller than controls and sterile [201]. Additionally, SIRT1-null mice utilize ingested food inefficiently, are hypermetabolic, contain inefficient liver mitochondria, have elevated rates of lipid oxidation and do not display an extended lifespan under caloric restriction [3608]. Heterozygous mice had a normal average lifespan [1922]. Mice with moderate overexpression of SIRT1 exhibit fat mass gain similar to controls exposed to a high-fat diet [1897]. Cardiac-specific low to moderate overexpression of SIRT1 attenuated age-dependent increases in cardiac hypertrophy, apoptosis, and expression of senescent biomarkers while a high level of overexpression had detrimental effects and induced cardiomyopathy [1930]. Overall, whole-body moderate overexpression of Sirt1 improves healthy ageing but does not increase mice lifespan [3266]. Brain-specific overexpression in mice results in moderately longer lifespan as females live 16% longer and males 9% longer [3268].

SIRT1 is overexpressed in calorie restricted rats, a response attenuated by insulin (INS) and IGF1 [1328]. Increased dosage of SIRT1 in pancreatic beta cells enhanced INS secretion [1481].

In Cockayne syndrome, an accelerated ageing disease, activation of SIRT1 through a high-fat diet and NAD(+) supplementation results in the rescue the mice from the associated progeroid phenotypes [3605]. In murine induced pluripotent stem cells, SIRT1 is necessary for telomere elongation after reprogramming and is required to maintain genomic stability, telomeric transcription and remodeling of telomeric chromatin. SIRT1-deficient induced pluripotent stem cells accumulate chromosomal aberrations and show a derepression of telomeric heterochromatin [3606]. In humans, increased levels of SIRT1 and SIRT3 have been associated with frailty [3607]. Although SIRT1 could impact on age-related diseases, such as type 2 diabetes, further studies are needed to establish its role in human ageing.

Cytogenetic information

Cytogenetic band
10q21.3
Location
67,884,669 bp to 67,918,390 bp
Orientation
Plus strand
Display region using the UCSC Genome Browser (GRCh38/hg38)

Protein information

Gene Ontology
Process: GO:0000012; single strand break repair
GO:0000122; negative regulation of transcription from RNA polymerase II promoter
GO:0000183; chromatin silencing at rDNA
GO:0000720; pyrimidine dimer repair by nucleotide-excision repair
GO:0000731; DNA synthesis involved in DNA repair
GO:0001525; angiogenesis
GO:0001542; ovulation from ovarian follicle
GO:0001678; cellular glucose homeostasis
GO:0001934; positive regulation of protein phosphorylation
GO:0001938; positive regulation of endothelial cell proliferation
GO:0002821; positive regulation of adaptive immune response
GO:0006260; DNA replication
GO:0006281; DNA repair
GO:0006325; chromatin organization
GO:0006342; chromatin silencing
GO:0006343; establishment of chromatin silencing
GO:0006344; maintenance of chromatin silencing
GO:0006346; methylation-dependent chromatin silencing
GO:0006364; rRNA processing
GO:0006366; transcription from RNA polymerase II promoter
GO:0006471; protein ADP-ribosylation
GO:0006476; protein deacetylation
GO:0006642; triglyceride mobilization
GO:0006974; cellular response to DNA damage stimulus
GO:0006979; response to oxidative stress
GO:0007283; spermatogenesis
GO:0007346; regulation of mitotic cell cycle
GO:0007517; muscle organ development
GO:0007569; cell aging
GO:0008284; positive regulation of cell proliferation
GO:0009267; cellular response to starvation
GO:0010046; response to mycotoxin
GO:0010460; positive regulation of heart rate
GO:0010629; negative regulation of gene expression
GO:0010667; negative regulation of cardiac muscle cell apoptotic process
GO:0010875; positive regulation of cholesterol efflux
GO:0010883; regulation of lipid storage
GO:0010906; regulation of glucose metabolic process
GO:0010934; macrophage cytokine production
GO:0010976; positive regulation of neuron projection development
GO:0014068; positive regulation of phosphatidylinositol 3-kinase signaling
GO:0014858; positive regulation of skeletal muscle cell proliferation
GO:0016032; viral process
GO:0016239; positive regulation of macroautophagy
GO:0016567; protein ubiquitination
GO:0016575; histone deacetylation
GO:0018394; peptidyl-lysine acetylation
GO:0030225; macrophage differentiation
GO:0030308; negative regulation of cell growth
GO:0030512; negative regulation of transforming growth factor beta receptor signaling pathway
GO:0031393; negative regulation of prostaglandin biosynthetic process
GO:0031648; protein destabilization
GO:0031937; positive regulation of chromatin silencing
GO:0032007; negative regulation of TOR signaling
GO:0032071; regulation of endodeoxyribonuclease activity
GO:0032088; negative regulation of NF-kappaB transcription factor activity
GO:0032720; negative regulation of tumor necrosis factor production
GO:0032868; response to insulin
GO:0032922; circadian regulation of gene expression
GO:0033158; regulation of protein import into nucleus, translocation
GO:0033210; leptin-mediated signaling pathway
GO:0034391; regulation of smooth muscle cell apoptotic process
GO:0034983; peptidyl-lysine deacetylation
GO:0035356; cellular triglyceride homeostasis
GO:0035358; regulation of peroxisome proliferator activated receptor signaling pathway
GO:0035774; positive regulation of insulin secretion involved in cellular response to glucose stimulus
GO:0042127; regulation of cell proliferation
GO:0042326; negative regulation of phosphorylation
GO:0042542; response to hydrogen peroxide
GO:0042595; behavioral response to starvation
GO:0042632; cholesterol homeostasis
GO:0042771; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
GO:0043065; positive regulation of apoptotic process
GO:0043066; negative regulation of apoptotic process
GO:0043124; negative regulation of I-kappaB kinase/NF-kappaB signaling
GO:0043161; proteasome-mediated ubiquitin-dependent protein catabolic process
GO:0043280; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process
GO:0043392; negative regulation of DNA binding
GO:0043433; negative regulation of sequence-specific DNA binding transcription factor activity
GO:0043518; negative regulation of DNA damage response, signal transduction by p53 class mediator
GO:0043524; negative regulation of neuron apoptotic process
GO:0044321; response to leptin
GO:0045348; positive regulation of MHC class II biosynthetic process
GO:0045471; response to ethanol
GO:0045599; negative regulation of fat cell differentiation
GO:0045722; positive regulation of gluconeogenesis
GO:0045739; positive regulation of DNA repair
GO:0045766; positive regulation of angiogenesis
GO:0045892; negative regulation of transcription, DNA-templated
GO:0045909; positive regulation of vasodilation
GO:0045944; positive regulation of transcription from RNA polymerase II promoter
GO:0046628; positive regulation of insulin receptor signaling pathway
GO:0050872; white fat cell differentiation
GO:0051097; negative regulation of helicase activity
GO:0051152; positive regulation of smooth muscle cell differentiation
GO:0051574; positive regulation of histone H3-K9 methylation
GO:0051898; negative regulation of protein kinase B signaling
GO:0055089; fatty acid homeostasis
GO:0060125; negative regulation of growth hormone secretion
GO:0060766; negative regulation of androgen receptor signaling pathway
GO:0061647; histone H3-K9 modification
GO:0070301; cellular response to hydrogen peroxide
GO:0070857; regulation of bile acid biosynthetic process
GO:0070914; UV-damage excision repair
GO:0070932; histone H3 deacetylation
GO:0071236; cellular response to antibiotic
GO:0071303; cellular response to vitamin B3
GO:0071356; cellular response to tumor necrosis factor
GO:0071441; negative regulation of histone H3-K14 acetylation
GO:0071456; cellular response to hypoxia
GO:0071479; cellular response to ionizing radiation
GO:0071900; regulation of protein serine/threonine kinase activity
GO:0090312; positive regulation of protein deacetylation
GO:0090335; regulation of brown fat cell differentiation
GO:0090400; stress-induced premature senescence
GO:1900034; regulation of cellular response to heat
GO:1900113; negative regulation of histone H3-K9 trimethylation
GO:1900181; negative regulation of protein localization to nucleus
GO:1901984; negative regulation of protein acetylation
GO:1902166; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
GO:1902176; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway
GO:1902237; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway
GO:1902617; response to fluoride
GO:1903427; negative regulation of reactive oxygen species biosynthetic process
GO:1904179; positive regulation of adipose tissue development
GO:1904373; response to kainic acid
GO:1904638; response to resveratrol
GO:1904644; cellular response to curcumin
GO:1904646; cellular response to beta-amyloid
GO:1904648; cellular response to rotenone
GO:1990619; histone H3-K9 deacetylation
GO:2000111; positive regulation of macrophage apoptotic process
GO:2000270; negative regulation of fibroblast apoptotic process
GO:2000480; negative regulation of cAMP-dependent protein kinase activity
GO:2000481; positive regulation of cAMP-dependent protein kinase activity
GO:2000505; regulation of energy homeostasis
GO:2000614; positive regulation of thyroid-stimulating hormone secretion
GO:2000619; negative regulation of histone H4-K16 acetylation
GO:2000655; negative regulation of cellular response to testosterone stimulus
GO:2000757; negative regulation of peptidyl-lysine acetylation
GO:2000773; negative regulation of cellular senescence
GO:2000774; positive regulation of cellular senescence
Cellular component: GO:0000790; nuclear chromatin
GO:0005634; nucleus
GO:0005635; nuclear envelope
GO:0005637; nuclear inner membrane
GO:0005654; nucleoplasm
GO:0005677; chromatin silencing complex
GO:0005719; nuclear euchromatin
GO:0005720; nuclear heterochromatin
GO:0005730; nucleolus
GO:0005737; cytoplasm
GO:0005739; mitochondrion
GO:0016605; PML body
GO:0030424; axon
GO:0030426; growth cone
GO:0033553; rDNA heterochromatin
GO:0035098; ESC/E(Z) complex
Function: GO:0001046; core promoter sequence-specific DNA binding
GO:0001077; transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding
GO:0002039; p53 binding
GO:0003714; transcription corepressor activity
GO:0003950; NAD+ ADP-ribosyltransferase activity
GO:0004407; histone deacetylase activity
GO:0005515; protein binding
GO:0008022; protein C-terminus binding
GO:0008134; transcription factor binding
GO:0017136; NAD-dependent histone deacetylase activity
GO:0019213; deacetylase activity
GO:0019899; enzyme binding
GO:0033558; protein deacetylase activity
GO:0034979; NAD-dependent protein deacetylase activity
GO:0035257; nuclear hormone receptor binding
GO:0042393; histone binding
GO:0042802; identical protein binding
GO:0043398; HLH domain binding
GO:0043422; protein kinase B binding
GO:0043425; bHLH transcription factor binding
GO:0046872; metal ion binding
GO:0046969; NAD-dependent histone deacetylase activity (H3-K9 specific)
GO:0051019; mitogen-activated protein kinase binding
GO:0070403; NAD+ binding
GO:1990254; keratin filament binding
Hide GO terms

Protein interactions and network

Protein-protein interacting partners in GenAge
TP53, WRN, E2F1, STAT3, IRS1, IRS2, AKT1, MYC, NCOR1, NBN, JUND, FOS, PPARA, PARP1, HSP90AA1, UBE2I, STK11, EP300, PML, AR, RB1, FOXO3, FOXO1, HSF1, RECQL4, RELA, SIRT1, HSPA9, HSPD1, MAPK8, JUN, FOXO4, PIK3R1, CREB1, APEX1, CDK1, MAPT, HDAC2, ESR1, MTOR, CTNNB1, CHEK2, ARNTL, CLOCK, HIC1, PPARGC1A, TP73, RICTOR
STRING interaction network
Protein-Protein network diagram for SIRT1

Retrieve sequences for SIRT1

ORF
ORF
CDS
CDS

Homologs in model organisms

Caenorhabditis elegans
sir-2.1
Danio rerio
sirt1
Drosophila melanogaster
Sir2
Mus musculus
Sirt1
Rattus norvegicus
Sirt1

In other databases

GenAge model organism genes
  • A homolog of this gene for Caenorhabditis elegans is present as sir-2.1
  • A homolog of this gene for Drosophila melanogaster is present as Sir2
  • A homolog of this gene for Mus musculus is present as Sirt1
GenDR gene manipulations
  • A homolog of this gene for Drosophila melanogaster is present as Sir2
  • A homolog of this gene for Mus musculus is present as Sirt1
  • A homolog of this gene for Caenorhabditis elegans is present as sir-2.1
LongevityMap
  • This gene is present as SIRT1
CellAge
  • This gene is present as SIRT1

Selected references

External links

EPD
ORF Accession
NM_012238
CDS Accession
NP_036370
OMIM
604479
HPRD
08381
Ensembl
SIRT1
UniProt/Swiss-Prot
SIR1_HUMAN
GeneCards
SIRT1
Entrez Gene
23411
UniGene
369779
GenAtlas
SIRT1
Internet
Search Google